CINECA IRIS Institutional Research Information System

Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study

PALUMBO, Antonio;CAVALLO, Federica;Hardan I;Lupo B;Redoglia V;Levin M;Corradini P;Pezzatti S;Patriarca F;Cavo M;Marcatti M;Pescosta N;Falcone AP;Ria R;Rossi D;Benevolo G;Cangialosi C;Galli M;Catalano L;Baraldi A;Carella AM;Cafro A;Siniscalchi A;Crippa C;Grammatico S;Cavalli M;Caravita Di Toritto T;Di Raimondo F;Nagler A;BOCCADORO, Mario

2011-01-01